In a large clinical trial, the vaccine was 83.7 percent effective at preventing two or more symptoms of respiratory illness in people over the age of 60
News Online
News Online
In a large clinical trial, the vaccine was 83.7 percent effective at preventing two or more symptoms of respiratory illness in people over the age of 60